From knowing the worst face of HIV up close to searching for the secret code of human immunity

The fact that her uncle contracted HIV and died from the complications of the infection when she was still studying biology at university finally pushed Gemma Moncunill (Barcelona, 1981) to want to dedicate herself to the research of the immune system and infectious diseases. “I had always been fascinated by the complexity with which the body was capable of defending itself, or how vaccines could train defense cells”, recalls this researcher, with a generous smile and sparkling eyes.

At home, they had always fueled her voracious, unquenchable curiosity about the world around her. As a child, on long car trips to the Vall d'Aran, where they used to spend holidays and weekends, Moncunill would sit in the front with her father and never stop asking him questions. "Dad, how does this and that machine work? What is nuclear fusion? Do androids dream of electric sheep?" And her father, patiently, would answer everything he knew.

“At 18, I was already very clear that I wanted to dedicate myself to research. Surely, I had a cinematic vision: that I would save half the planet or find a cure for some deadly disease”, Moncunill recalls, laughing, and adds: “Perhaps I didn't really know what research was, but I had the motivation to understand, to solve complex problems, and from there build something”.

This motivation is the engine that has led this researcher, one of the star signings of the Caixa Research Institute –the first research center specializing in immunology in the Iberian Peninsula and one of the few in the world, which has just started operating in Barcelona– to make pivotal contributions to understanding how the body learns to defend itself from infections. Now, Moncunill leads a research group with which she will try to answer how to train the immune system so that it protects us better. And, ultimately, to map an immense and still little-known territory such as the functioning of human immunity.

Deeply involved in family history, she began by scrutinizing the AIDS virus. However, she felt that at the time that research was too focused on high-income countries and not enough on helping lower-income countries, where not only HIV, but also malaria and other diseases that always go hand in hand with poverty, prey on young children and pregnant women. As a researcher at the Barcelona Institute for Global Health (ISGlobal), she worked in Mozambique and collaborated with other sub-Saharan countries where malaria is endemic during the rollout of the RTS,S vaccine to understand why it protected and why it did so so differently.

“Vaccines designed in Europe and the United States, where genetics and environmental exposures are very different, do not work as well in Africa,” Moncunill points out. “And they are even less effective in children, because they have an immune system still under development, very different from that of adults, which responds differently,” she highlights, while recalling that “there are no resources dedicated to this disease, and this is crucial, because to advance in science considerable resources are needed in a sustained way.”

The challenge now, she considers, is to incorporate the massive analysis of biological data to understand the global behavior of the immune system and thus be able to answer questions such as why some people develop protection and others do not, and how we can use this knowledge to design more effective and precise vaccines that generate a long-term immune response. “There are vaccines that work extremely well, such as the human papillomavirus vaccine. My goal is to find the mechanisms to understand why some of these drugs work so well and be able to reproduce them so that all vaccines work just as well,” she says.

Gemma Moncunill's family photo

This immunologist shows a photograph where she appears in the foreground when she would be no more than two or three years old. Behind her are her aunt and uncle, both already ill with AIDS at the time. This researcher recalls how, when she was still very young, she first saw her aunt die. And years later, her uncle died from complications related to HIV and from the many adverse effects that antiretrovirals had at the time. “Personal involvement was my driving force, it made me want more than anyone else to go through that. I wanted to solve it.”